Trial Outcomes & Findings for Repetitive TMS & Cognitive Training in Adults With Schizophrenia (NCT NCT03741751)

NCT ID: NCT03741751

Last Updated: 2026-03-10

Results Overview

Evaluate differences in neuropsychological functioning between active and sham rTMS groups using the Screen for Cognitive Impairment in Psychiatry (SCIP). Scores are reported as Z-scores standardized to age-adjusted normative data. A Z-score of 0 represents the population mean, and each unit reflects one standard deviation from that mean. Higher Z-scores indicate better cognitive performance. Scores are interpreted relative to normative expectations rather than a diagnostic threshold. Change scores represent the value at 2 weeks minus the baseline value.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

12 participants

Primary outcome timeframe

2 weeks

Results posted on

2026-03-10

Participant Flow

Participants were recruited from the St. Louis Metropolitan area.

Twelve participants provided informed consent; six were randomized and six were not assigned to an intervention.

Participant milestones

Participant milestones
Measure
Active rTMS With Computerized Cognitive Training
Participants will receive 6 sessions of active rTMS followed by a computerized cognitive training session over 2 weeks.
Sham rTMS With Computerized Cognitive Training
Participants will receive 6 sessions of sham rTMS followed by a computerized cognitive training session over 2 weeks.
Overall Study
STARTED
3
3
Overall Study
COMPLETED
2
3
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Repetitive TMS & Cognitive Training in Adults With Schizophrenia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active rTMS With Computerized Cognitive Training
n=3 Participants
Participants will receive 6 sessions of active rTMS followed by a computerized cognitive training session over 2 weeks.
Sham rTMS With Computerized Cognitive Training
n=3 Participants
Participants will receive 6 sessions of sham rTMS followed by a computerized cognitive training session over 2 weeks.
Total
n=6 Participants
Total of all reporting groups
Age, Continuous
44 years
STANDARD_DEVIATION 1.73 • n=68 Participants
46 years
STANDARD_DEVIATION 19.68 • n=69 Participants
45 years
STANDARD_DEVIATION 12.54 • n=137 Participants
Sex: Female, Male
Female
0 Participants
n=68 Participants
2 Participants
n=69 Participants
2 Participants
n=137 Participants
Sex: Female, Male
Male
3 Participants
n=68 Participants
1 Participants
n=69 Participants
4 Participants
n=137 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=68 Participants
0 Participants
n=69 Participants
0 Participants
n=137 Participants
Race (NIH/OMB)
Asian
0 Participants
n=68 Participants
0 Participants
n=69 Participants
0 Participants
n=137 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=68 Participants
0 Participants
n=69 Participants
0 Participants
n=137 Participants
Race (NIH/OMB)
Black or African American
2 Participants
n=68 Participants
2 Participants
n=69 Participants
4 Participants
n=137 Participants
Race (NIH/OMB)
White
1 Participants
n=68 Participants
1 Participants
n=69 Participants
2 Participants
n=137 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=68 Participants
0 Participants
n=69 Participants
0 Participants
n=137 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=68 Participants
0 Participants
n=69 Participants
0 Participants
n=137 Participants
WHODAS Total Score
12.00 Score
STANDARD_DEVIATION 19.92 • n=68 Participants
50.67 Score
STANDARD_DEVIATION 42.85 • n=69 Participants
31.33 Score
STANDARD_DEVIATION 35.60 • n=137 Participants

PRIMARY outcome

Timeframe: 2 weeks

Evaluate differences in neuropsychological functioning between active and sham rTMS groups using the Screen for Cognitive Impairment in Psychiatry (SCIP). Scores are reported as Z-scores standardized to age-adjusted normative data. A Z-score of 0 represents the population mean, and each unit reflects one standard deviation from that mean. Higher Z-scores indicate better cognitive performance. Scores are interpreted relative to normative expectations rather than a diagnostic threshold. Change scores represent the value at 2 weeks minus the baseline value.

Outcome measures

Outcome measures
Measure
Active rTMS With Computerized Cognitive Training
n=3 Participants
Participants will receive 6 sessions of active rTMS followed by a computerized cognitive training session over 2 weeks.
Sham rTMS With Computerized Cognitive Training
n=3 Participants
Participants will receive 6 sessions of sham rTMS followed by a computerized cognitive training session over 2 weeks.
Difference in Groups on Neuropsychological Testing
1.89 Z-score
Standard Deviation 1.67
0.48 Z-score
Standard Deviation 1.01

SECONDARY outcome

Timeframe: 2 weeks

Disability was measured using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0), a standardized instrument assessing functional impairment across multiple domains of daily living. Total scores range from 0 to 100, with higher scores indicating greater disability. Change scores were calculated as the value at 2 weeks minus the baseline value.

Outcome measures

Outcome measures
Measure
Active rTMS With Computerized Cognitive Training
n=3 Participants
Participants will receive 6 sessions of active rTMS followed by a computerized cognitive training session over 2 weeks.
Sham rTMS With Computerized Cognitive Training
n=3 Participants
Participants will receive 6 sessions of sham rTMS followed by a computerized cognitive training session over 2 weeks.
Change in WHODAS Total Score From Baseline to 2 Weeks
-1.33 WHODAS total score change
Standard Deviation 2.31
-10.33 WHODAS total score change
Standard Deviation 11.50

Adverse Events

Active rTMS With Computerized Cognitive Training

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Sham rTMS With Computerized Cognitive Training

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Active rTMS With Computerized Cognitive Training
n=3 participants at risk
Participants will receive 6 sessions of active rTMS followed by a computerized cognitive training session over 2 weeks.
Sham rTMS With Computerized Cognitive Training
n=3 participants at risk
Participants will receive 6 sessions of sham rTMS followed by a computerized cognitive training session over 2 weeks.
Nervous system disorders
headache
33.3%
1/3 • Number of events 1 • From enrollment until the end of participation, up to 2 weeks.
Adverse events were collected systematically at each study visit via participant self-report and clinician inquiry. Events were classified as serious or non-serious according to standard ClinicalTrials.gov definitions. Expected adverse events, including headache, were listed in the informed consent document.
0.00%
0/3 • From enrollment until the end of participation, up to 2 weeks.
Adverse events were collected systematically at each study visit via participant self-report and clinician inquiry. Events were classified as serious or non-serious according to standard ClinicalTrials.gov definitions. Expected adverse events, including headache, were listed in the informed consent document.

Additional Information

Rita Haddad

Rita Haddad

Phone: 314-747-7851

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place